Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
<h4>Background</h4>Surveillance for hepatocellular carcinoma (HCC) has level I evidence among patients with hepatitis B but only level II evidence in patients with cirrhosis. This lack of randomized data has spurred questions regarding the utility of HCC surveillance in this patient popu...
Main Authors: | Amit G Singal, Anjana Pillai, Jasmin Tiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-04-01
|
Series: | PLoS Medicine |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24691105/?tool=EBI |
Similar Items
-
Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma
by: Nikita Sandeep Wagle, et al.
Published: (2022-05-01) -
Effects of Curative-Intent Treatments on Hepatocellular Carcinoma Survival in Alcohol-Related Cirrhosis: A Nationwide Study
by: Kraglund F, et al.
Published: (2023-01-01) -
Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
by: Mindie H. Nguyen, et al.
Published: (2022-12-01) -
Factors Associated with Surveillance for Early Detection of Hepatocellular Carcinoma in Liver Cirrhosis Patients
by: Ario Perbowo Putra, et al.
Published: (2017-12-01) -
Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
by: Yi-Te Lee, et al.
Published: (2023-04-01)